Premature ejaculation: assessed properly, treated to the pattern.

Premature ejaculation (PE) is reaching climax sooner than desired during sexual activity, on a persistent basis, causing distress to one or both partners. The AUA/SMSNA Guideline defines lifelong (primary) PE using two criteria: ejaculation within about 2 minutes of initiation of penetrative sex and the perceived inability to delay it.⁵

PE is the most common sexual concern reported by men. Approximately one in three experience PE at some point in their lives, and roughly 20-30% have it persistently.¹ Despite this prevalence, only a small fraction seek treatment - partly because of embarrassment, partly because many don't realise effective treatments exist.

PE is classified into four types: lifelong (primary) PE, present from first sexual experiences, acquired (secondary) PE, which develops after a period of normal control, variable PE (irregular occurrence in otherwise normal-functioning men), and subjective PE (perceived PE in men with objectively normal ejaculation time). The type matters, because treatment approaches differ.

The distinction that changes management most is primary versus secondary. Primary (lifelong) PE has been present since a man became sexually active and is more biologically driven, so treatment is directed at ejaculatory control itself: behavioural techniques, topical anaesthetics and on-demand dapoxetine. Secondary (acquired) PE represents a change from previously normal control, and usually has an identifiable medical or psychological cause. In secondary PE the first step is to find and treat that cause.⁵

PE is highly treatable. Most patients see meaningful improvement with evidence-based treatment, particularly when behavioural techniques are combined with pharmacological options.

PE has both biological and psychological contributors, and most cases involve a combination. Understanding the dominant factor shapes the treatment approach.

Serotonergic differences are the strongest biological contributor to lifelong (primary) PE. Lower serotonin signalling in specific brain regions reduces the threshold for ejaculation. This is why SSRIs such as on-demand dapoxetine, which raise serotonin signalling, are used for PE.

Penile sensitivity can contribute to lifelong (primary) PE, because heightened sensory feedback triggers ejaculation more readily. Topical anaesthetics directly address this mechanism.

Anxiety and psychological factors are the strongest contributors to acquired (secondary) PE. Performance anxiety, relationship stress, depression, and life pressure all reduce ejaculatory control. The pattern is often "fast → anxious → faster" - a self-reinforcing cycle that responds well to combined behavioural and pharmacological treatment.

Co-occurring erectile dysfunction is present in a meaningful proportion of patients with acquired (secondary) PE. Treating ED often improves the PE, and treating one without the other can worsen the other. Clinical evaluation always considers both.

Hormonal factors including testosterone deficiency and thyroid dysfunction can contribute. Hyperthyroidism in particular is associated with PE, so thyroid function is included in evaluation where indicated.⁶

Prostate inflammation (prostatitis) is associated with acquired (secondary) PE in some patients. Where pelvic discomfort or urinary symptoms accompany PE, prostatic evaluation is part of the workup.

Substance use including some recreational drugs and excessive alcohol can affect ejaculatory control. Withdrawal matters as much as use: stopping opioids, and occasionally stopping long-standing antidepressant treatment, can shorten latency. Medication review is part of every consultation.

Family history and anatomy. Lifelong PE shows familial clustering in several studies, which supports the neurobiological explanation rather than a behavioural one. In a minority of men a short or tight frenulum raises sensitivity enough to matter, which is why a brief genital examination is part of assessment.

General health factors matter too, so comprehensive health screening is part of the men's sexual health workup, particularly for acquired (secondary) PE in patients over 40.

Before your visit. Your personal health concierge shares a brief intake form covering symptom history, type of PE (primary or secondary), sexual history including partner context, current medications, and any co-occurring concerns. The intake helps focus consultation time on assessment rather than data collection.

During your visit. The consultation lasts 30-45 minutes. Our medical team takes a focused history covering symptom pattern, onset, situational variability, partner perspective if helpful, and screening for co-occurring conditions (ED, anxiety, depression, prostatic symptoms). Physical examination is brief and usually limited to general assessment unless other concerns emerge.

Investigations are not usually needed for straightforward primary PE. Where secondary PE or co-occurring concerns are present, bloodwork may be added (testosterone, thyroid function, prolactin, glucose). Urinalysis if prostatic symptoms.

After your visit. Treatment options are discussed at the first consultation, and an initial approach is usually started immediately. Follow-up is structured at 4 weeks (response assessment), 12 weeks (refinement), and longer-term as needed. Behavioural techniques are reinforced through follow-up.

Confidentiality. Records are encrypted. Hisential does not share information with employers, family, or insurers without your explicit consent, except where required by regulations or law. Partner involvement is encouraged but always at your discretion.

A formal diagnosis needs three things present together, not just a short time on the clock. Time: ejaculation consistently within about one minute of penetration for lifelong PE, or a clear reduction from a man's own previous latency, commonly to around three minutes or less, for acquired PE. Control: an inability to delay ejaculation on all or nearly all occasions. Consequence: distress, frustration or avoidance of intimacy.

The third criterion is the one most often forgotten and the one that matters most. A man who ejaculates in four minutes and is entirely content does not have a disorder. A man who ejaculates in three minutes and whose relationship is suffering has something worth treating. Distress is part of the diagnosis, not an optional extra.

Population studies that measured latency directly put the median at roughly five to six minutes, with a very wide spread, and the great majority of men falling between one and ten minutes. Two things follow. Many men who believe they are premature are inside the normal range and are comparing themselves against pornography, where duration is an editing decision. And the group who genuinely meet the one-minute criterion is smaller than the group who worry about it.

Self-reported PE runs at roughly twenty to thirty percent of adult men across surveys in Asia and internationally. Applying the strict one-minute criterion brings that figure down to the low single digits. That gap is clinically useful in itself: a meaningful share of men who come in are suffering from expectation rather than pathology, and an honest conversation serves them better than a prescription.

A significant proportion of men who present describing PE turn out to have something else, and separating them changes the treatment entirely.

Erectile dysfunction presenting as speed. A man who cannot reliably maintain an erection learns, often without recognising it, to hurry to ejaculation before the erection fades. The complaint is speed; the problem is rigidity. Treating the erectile dysfunction frequently resolves the ejaculatory pattern with no PE-specific treatment at all.

Normal variation misread as dysfunction. Some men who ask for treatment have latencies of five, seven or ten minutes and a belief, built on pornography and locker-room arithmetic, that this is inadequate. That is not premature ejaculation. It needs accurate information, and often a conversation with a partner whose expectations turn out to be different from what was assumed.

Variable and subjective patterns. Early ejaculation that happens inconsistently is normal variation. Believing you are premature despite a latency well inside the normal range is subjective PE. Neither is a disorder in the strict sense, though the distress is real and deserves to be addressed.

Men often arrive wanting to know which treatment is best. The more useful question is which pattern of use fits your situation, because the options differ less in effectiveness than in how they are lived with.

Everything in the medication rows above is prescription-only in Singapore and is dispensed after a consultation. Combination treatment consistently outperforms any single approach.

Treatment works best in a defined order, because the slow levers need to start early while the fast ones carry the first few weeks.

1. Assessment to separate lifelong from acquired PE and to screen for treatable causes.
2. Treat any identified cause, erectile difficulty above all.
3. Begin behavioural techniques and pelvic floor training, which take weeks to show.
4. Add a topical or on-demand oral option for immediate benefit while the training takes effect.
5. Review at four to six weeks and step up to daily treatment if on-demand is not enough.
6. Add psychological or couple support where anxiety or relationship strain persists.
7. Taper medication once behavioural gains are established, if you want to.

Skipping step two is the most common reason treatment underperforms.

Treatment fails as often through poor measurement as through poor choice of treatment, and two errors dominate.

The first is judging progress by a single encounter. Latency naturally varies with arousal, time since last ejaculation, alcohol, fatigue, novelty and stress. One disappointing occasion three weeks into a programme tells you nothing, and men who stop on that basis routinely discard something that was working.

The second is the stopwatch. Timing yourself turns sex into a performance under measurement, which raises exactly the anticipatory anxiety that shortens latency. A rough weekly impression across several occasions is more useful, together with two questions that matter more than the clock: how much control over the moment do you feel, and how much distress is this causing you and your partner. The validated tools used in clinic assess control and distress rather than seconds, for precisely this reason.

Expect a stepwise pattern rather than a smooth line: an early jump when a topical or oral option is introduced, a plateau, then slower and more durable improvement over six to twelve weeks as behavioural control and pelvic floor strength develop.

If eight to twelve weeks of a properly combined approach has produced little change, the explanations are usually specific rather than mysterious.

An untreated underlying cause is the most common: erectile difficulty that was never asked about, chronic prostatitis, or an untreated thyroid abnormality. Inconsistent technique is next, since behavioural methods need regular practice and few men do them as often as prescribed. Under-dosing or stopping oral treatment too early is third, because daily treatment needs one to two weeks before it can be judged. And in some cases the dominant driver is relationship conflict or a psychological factor that medication cannot reach, which is where couple-based therapy earns its place.

Reassessment works through each of these in turn before concluding that the condition is refractory. Genuinely treatment-resistant PE is uncommon.

Several widely repeated strategies do not hold up, and two of them carry real risk.

• Thick condoms and distraction. Occasionally helpful at the margins, unreliable as a strategy, and distraction tends to reduce enjoyment for both partners.
• Alcohol. Delays ejaculation at the cost of erectile quality and judgement, and builds a dependence on it for sex.
• Over-the-counter stamina supplements. No consistent evidence, and Singapore's Health Sciences Authority has repeatedly recalled such products for containing undeclared prescription ingredients. Products sold online promising instant results are unregulated and can be dangerous, particularly alongside heart medication.
• Surgery. Reserved for a small minority with a specific anatomical cause, not a general treatment.